Acoustofluidic multimodal diagnostic system for Alzheimer's disease

Area of Science:

• Biomedical Engineering
• Neuroscience
• Analytical Chemistry

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder with significant global impact.
• Early diagnosis of AD is crucial but remains a considerable challenge.
• Current diagnostic methods often lack the sensitivity or speed required for timely intervention.

Purpose of the Study:

• To develop an integrated acoustofluidics-based diagnostic system (ADx) for early Alzheimer's disease detection.
• To achieve clinically accurate, sensitive, and rapid detection of AD biomarkers from human plasma.
• To combine acoustics, microfluidics, and orthogonal biosensors for enhanced diagnostic performance.

Main Methods:

• Designed and fabricated a surface acoustic wave-based acoustofluidic separation device for biomarker isolation and purification.
• Integrated multimodal biosensors using in-situ patterned ZnO nanorod arrays and silver nanoparticles.
• Utilized surface-enhanced Raman scattering (SERS) and electrochemical immunosensing for label-free detection.

Main Results:

• Achieved high signal-to-noise ratio through acoustofluidic separation of AD biomarkers.
• Demonstrated label-free detection of AD biomarkers in clinical plasma samples.
• Obtained high sensitivity and specificity in differentiating AD patients from healthy controls.

Conclusions:

• The integrated ADx system offers a promising solution for the early diagnosis of Alzheimer's disease.
• The combination of acoustofluidics and multimodal biosensors enhances detection accuracy and speed.
• This technology has the potential to significantly improve clinical management and patient outcomes for AD.